DeepSeek’s Liang Wenfeng says AGI, open source and cost discipline are the company’s core strategy
elsewhere别处发生 · wechat · 2026-07-22
A long WeChat article compiles 52 statements attributed to DeepSeek founder Liang Wenfeng, centered on the company’s strategy, open source stance, pricing, and AGI roadmap.
Main takeaways
- DeepSeek says its only real line is AGI; product work, multimodal, 3D, video generation, and world models are not the main path.
- The company treats coding agents as the most important near-term direction, and sees continuous learning as the next big bottleneck after CoT and agents.
- Liang argues that cost efficiency is the top competitive axis, with time to market second and user experience third.
- He frames open source as a strategic form of restraint: it improves team cohesion, helps the ecosystem, and can still fit a business model that only seeks reasonable profit.
- He says the China–US AI gap is mostly resources rather than talent, claims domestic talent is not scarce, and expects the industry to eventually consolidate into only a few large model companies.
- DeepSeek says it does not want to become the next super app or maximize short-term commercial gain; keeping the team stable is presented as the core constraint and also the main risk.
Related event: DeepSeek Founder's Investor Call Reveals AGI Roadmap and Compute Plans(37 posts)→
More from AGI Musings
- Lab monkeys at $30-80K each: a 4-year breeding cycle is the real preclinical drug bottleneck — zebird0 · 2026-10-27
- CJR: journalists should stop hyping AI's supposed humanity — just say 'rogue' — ShakeelHashim · 2026-10-27
- PhD applicant emails up 4x YoY due to AI — writing without AI now makes you stand out — AI4Code · 2026-10-27
- Weil's collapse shows BigLaw dies from eroding belief, not a broken business model — jkubicki · 2026-10-27
- All 8 Transformer paper authors left Google, and rival labs captured most of the frontier value — signulll · 2026-10-27
- Anthropic's S-1 pledges AI for curing diseases and serving 4.6B underserved patients — petergyang · 2026-10-27